Zachary Zumsteg
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer (NCT06445114) | Zachary Zumsteg | 2025-05-12 |
Track Zachary Zumsteg automatically
Every clearance here is in the API, with alerts when new ones post.